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An epidemiological survey on Blastocystis was carried out enrolling a total of 2524 subjects re-
ferred to the Umberto I Academic Hospital in Rome, for the routine parasitological exams, dur-
ing 2017–2018. The studied population included a sample of immunocompromised individuals
(N = 130) followed at the same hospital.
DNA sequencing of the small subunit rRNA gene (SSU rDNA) locus was performed on samples
positive to the coproparasitological analysis to molecular characterize the Blastocystis-subtypes.
Microscopical analysis detected Blastocystis in 192/2524 (7.6%) of the enrolled subjects. It was
the organism most frequently identified in the analysed faecal samples diagnosed in single in-
fection (5.6%) or in co-infection with other enteric protozoa (2%). Furthermore, it was found
mainly in immunocompromised patients (22.3%) compared to immunocompetent ones (6.8%).
As expected, ST3 was the most occurring subtype identified in 40% of the subjects, followed by
ST1 (29%), ST2 (16%), ST4 (12%), and ST7 (3%).
Next-generation sequencing (NGS) of the 16S rDNA was performed on a sub-sample of
Blastocystis-ST3-carriers, homogenous by age and gender, as well as on Blastocystis-free sub-
jects, to profile and compare their gut bacterial composition. A higher bacterial diversity was
found in ST3-Blastocystis-carriers, which exhibited a high abundance of Prevotella,
Methanobrevibacter and Ruminococcus while, a high percentage of Bacteroides was found in
Blastocystis-free subjects.
This study evidenced the presence of Blastocystis in 7.6% of faecal samples in Italy and a high
circulation of the protist among immunocompromised patients (22.3%). Molecular characteri-
zation of positive samples evidenced the occurrence of five different subtypes, including zoo-
notic ST such as the ST7, highlighting the risk of transmission from animals. Study of the gut
microbiota composition confirms previous evidences according to which, the colonisation by
Blastocystis would be linked with an eubiotic gut characterized by potentially beneficial species
such as Prevotella and Ruminococcus, rather than with a dysbiotic state, with a high abundance
of Enterobacteriaceae, and corroborated the role of the protist as “an old friend” of the human
gut.
© 2020 The Authors. Published by Elsevier Ltd on behalf of World Federation of Parasitologists.








Parasite Epidemiology and Control 9 (2020) e00134
⁎ Corresponding author at: Department of Public Health and Infectious Diseases, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy.
E-mail address: simonetta.mattiucci@uniroma1.it. (S. Mattiucci).
https://doi.org/10.1016/j.parepi.2020.e00134
2405-6731/© 2020 The Authors. Published by Elsevier Ltd on behalf ofWorld Federation of Parasitologists. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
Contents lists available at ScienceDirect
Parasite Epidemiology and Control
j ourna l homepage: www.e lsev ie r .com/ locate /parep i
1. Introduction
Blastocystis is currently known as belonging to the Stramenopiles, a complex and heterogeneous evolutionary assemblage of
heterotrophic and photosynthetic protozoa (Silberman et al., 1996; Arisue et al., 2002; Riisberg et al., 2009). It colonises intestine
of humans and wide range of animals. In humans, it exhibits a worldwide distribution, with a prevalence from 0.5%–30% and 30–
76% in industrialized and developing countries, respectively (Alfellani et al., 2013). Molecular study based on the small subunit
ribosomal RNA (SSU-rDNA) evidenced an extensive genetic heterogeneity allowing the identification in mammalian and avian
hosts of at least 26 divergent lineages, termed subtypes (STs), which could be considered arguably separate species (Alfellani
et al., 2013; Zhao et al., 2017; Maloney et al., 2019). Ten of the 26 subtypes, ST-1 to ST-9 and ST-12, have been identified in
human samples, and all, except for ST-9, have also been reported in animals (Ramírez et al., 2016; Stensvold and Clark, 2016).
Despite the pathogenetic role of Blastocystis has been the subject of many investigations (Sheehan et al., 1986; Dogruman-Al
et al., 2009; Poirier et al., 2012; Wawrzyniak et al., 2013; Azizian et al., 2016; Mattiucci et al., 2016; Stensvold et al., 2009), it's
so far remaining unclear. Several authors suggested that it could be linked to the impact of the protist on the gut microbiota. Anal-
ysis of the microbial communities in healthy individuals or affected by intestinal disorders evidenced three main microbiota pat-
terns, named enterotypes, characterized by three dominant bacteria clusters: Bacteroides (enterotype I), Prevotella (enterotype II),
or Ruminococcus (enterotype III) (Arumugam et al., 2011). Each enterotype harbours different bacteria genera, defines a distinc-
tive way of generating energy and seem to be linked to dietary habits (Rinninella et al., 2019). Recent NGS-based studies associ-
ated Blastocystis with higher diversity of gut microbiota, low Body Mass Index (BMI), and the enterotype II and III (Andersen et al.,
2015; Andersen and Stensvold, 2016). Furthermore Blastocystis was also linked to an eubiotic state, characterized by a preponder-
ance of potentially beneficial species, belonging mainly to the phyla Firmicutes and Bacteoides, instead of those of the phylum
Protebacteria, since significantly higher Faecalibacterium prausnitzii-Escherichia coli ratio was found in Blastocystis-positive than
in Giardia-positive individuals (Iebba et al., 2016a).
Conversly, Nourrisson and colleagues evidenced a decrease of faecal microbiota protective bacteria in Blastocystis-colonised in-
dividuals (Nourrisson et al., 2014). Moreover, it has been suggested that microbiota composition in Blastocystis-carriers may be
dependent on the organism's ST and that certain isolates of Blastocystis, as the ST7, potentially lead to an imbalance of the gut
microbiota (Yason et al., 2019; Tito et al., 2019). Finally, it has been proposed that some populations are more susceptible to
Blastocystis colonisation (Wawrzyniak et al., 2013). Thus, this protozoon is frequently found in immunocompromised individuals,
such as those with human immunodeficiency virus/acquired immunodeficiency syndrome or cancer (Piranshahi et al., 2018;
Kurniawan et al., 2009; Tan et al., 2009). Studies of gut microbiota in HIV-infected patients evidenced a change in the
Bacteroides:Prevotella ratio (Williams et al., 2016), which could also be linked to sexual practice and lifestyle rather than HIV in-
fection and Highly Active AntiRetroviral Therapy (HAART)-treatment (Noguera-Julian et al., 2016).
However, no specific investigations have been so far conducted to investigate on the relationship between the presence of
Blastocystis and the faecal microbiota composition in such group of patients.
Aim of this study was to: i) assess the circulation of Blastocystis among patients refereed to the Academic Hospital "Policlinico
Umberto I" for the routine parasitological exams; ii) molecular characterize the Blastocystis-STs from positive subjects; iii) analyse
the faecal microbial composition from a cohort of patients, including immunocompromised subjects, found positive to Blastocystis-
ST3.
2. Materials and methods
2.1. Faecal samples collection
Faecal samples were collected from subjects refereed to the Diagnostic Parasitology laboratory and to the Department of Trans-
lation and Precision Medicine of the Academic Hospital “Policlinico Umberto I”, during the years 2017–2018. This epidemiological
survey was carried out after the previously study on Blastocystis STs from 189 isolates, collected during the years 2012–2014
among mildly symptomatic patients, or those affected by inflammatory bowel disease (IBD), irritable bowel syndrome (IBS) or
chronic diarrhoea, or otherwise immunosuppressed referred at the same hospital (Mattiucci et al., 2016). In such survey six sub-
types (ST1, 2, 3, 4, 6, 8) were detected and significant occurrence of Blastocystis ST4 in patients suffering from IBS, IBD or chronic
diarrhoea was observed (Mattiucci et al., 2016).
Demographic data were obtained from subjects included in the study, as well as their written informed consent. The study was
approved with respect to the Helsinki Declaration by the Ethical Committee of the Academic Hospital “Policlinico Umberto I” (li-
cense number: n. 4836).
2.2. Laboratory procedures
From one to three faecal samples were collected from each subject and submitted to the microscopic observation of the wet
smears stained with Lugol, directly and after Ridley concentration (Ridley and Hawgood, 1956). Genomic DNA was then extracted
from samples positive to the microscopic observation and submitted to PCR amplification using primers previously described
(Scicluna et al., 2006), which target a fragment of about 600 bp from the Blastocystis-SSU rDNA gene, following PCR protocol
and conditions as previously described (Mattiucci et al., 2016). The resulting chromatograms were analysed and edited by
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using the software Chromas version 2.33 (Technelysium Pty Ltd., Australia). The sequences obtained were compared to those of
Blastocystis STs previously deposited in GenBank using the BLAST application (www.ncbi.nlm.nih.gov/BLAST). The STs were iden-
tified by determining the exact match or closest identity (99%), according to the classification given by Stensvold et al. 2007
(https://pubmlst.org/blastocystis/). NGS of the bacterial 16S rRNA was thus carried out on a subsample of subjects Blastocystis-
free and Blastocystis-carriers homogeneous by age (b40 years-old), gender (male) and found positive for the same subtype
(ST3). NGS and data analysis was supported by BMR Genomics (Padua, Italy). Briefly, V3-V4 regions of 16S rRNA gene were am-
plified using the primers Pro341F (5′-CCTACGGGNBGCASCAG-3′) and Pro805R (5′-GACTACNVGGGTATCTAATCC-3′) (Takahashi
et al., 2014). Primers were modified with forward overhang: 5′-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAG-[locus-specific se-
quence]-3′ and with reverse overhang: 5′-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACA-[locus-specific sequence]-3′ necessary
for dual index library preparation, following Illumina protocol (https://web.uri.edu/gsc/files/16s-metagenomic-library-prep-
guide-15044223-b.pdf). PCR mix was composed as follows: 5 μl DNA, 6.2 μl of mix (Taq Platinum-Thermo Fisher, Primer and
MgSO4) and 13.8 μl DNA-se free water. Amplification conditions were: 1 cycle at 94 °C for 1 min, 25 cycles at 94 °C for 1 min,
55° for 30 s, 68° for 45 s and 1 final cycle at 68 °C for 7 min. Amplicons of expected size (about 476 bp) were purified by
means Beads Amplure XP 0,8×, normalized, pooled and run on Illumina MiSeq with 2 × 300 bp approach in order to produce
about 50000 reads (±20%).
The sequencing reads were filtered for average quality (Q N 30), and R1 and R2 were merged using FLASH with default param-
eters. QIIME software version 1.9.1 was used to perform the full analysis of OTUs selected for the statistical analysis using the
pick_closed_reference_otus.py wrapper from the Greengenes reference database (13.8 version) (Caporaso et al., 2010).
2.3. Data analysis
To test the distribution of different Blastocystis subtypes among different age groups and gender, the Wilcoxon signed-rank
non-parametric test was used. Data were analysed using IBM SPSS, version 21.0 (SPSS Inc., Chicago, USA). Alpha (within a com-
munity) and beta (between communities) diversity metrics, as well as taxonomic community assessments, were produced using
QIIME 1.9.1 scripts on the normalized read counts. The following indexes were calculated for each sample: Chao1 bias-corrected
and observed OTUs. Alpha-diversity rarefaction curves were produced by plotting these several diversity metrics against the num-
ber of sequences considered from a sample. Differences in diversity between Blastocystis-carriers (both immunocompetent and
immunocompromised) and Blastocystis-free subjects were tested by Kruskal-Wallis test using the Stats Direct Statistical software
v. 3.1.20 (http://www.statsdirect.com. England: StatsDirect Ltd. 2013). Multivariate analysis was done through the
compare_category.py script of QIIME. Differences in beta diversity (weighted UniFrac distances) were identified using Analysis
of Similarity (ANOSIM) and the effect of size indicated by an R-value (between −1 and +l), with a value of 0 representing the
null hypothesis1. Adonis (ANOVA tests group) was applied to verify variations within a category and between categories. Analyses
were performed among the required groups and on different metrics: weighted and unweighted. MatagenomeSeq was used to
calculate species differential abundance between the groups. The Mann-Whitney test was then applied to evaluate the signifi-
cance of the comparison. P-values b0.05 were considered statistically significant.
3. Results
3.1. Study subjects and coproparasitological results
During the years 2017–2018 a total of 2524 faecal samples were screened for intestinal protozoa among the patients admitted
at the Diagnostic Parasitology laboratory, “Policlinico Umberto I”, Rome, Italy. The study population included 2394 subjects re-
ferred at the hospital for the routinely copro-parasitological analyses, without any indication about their clinical status, and 130
HIV-positive patients regularly followed at the Department of Translation and Precision Medicine of the same hospital.
Microscopical analysis detected Blastocystis in 192/2524 (7.6%) of the enrolled subjects. In detail, Blastocystis was frequently
found in the group of immunocompromised patients (22.3%) compared to immunocompetent ones (6.8%).
As expected, it was the most frequent organism identified in the faecal samples diagnosed in single infection (5.6%) or in co-
infection with other enteric protozoa (2%), followed by Endolimax nana (2.5%), Entamoeba coli (1.7%), Giardia intestinalis (1.2%),
Entamoeba complex (0.5%), Iodamoeba butschlii (0.3%).
Blastocystis-carriers were mainly males (65%), mean age 47.35 (95% CI, 40.94–54.74), 62% were from Italy.
3.2. Molecular characterization of Blastocystis subtypes
A total of 142/192 stool samples positive to the microscopical analysis were successfully DNA extracted and subtyped by se-
quences analysis of the SSU-rDNA (barcode region). BLAST searches allowed the identification of 5 STs, with different percentage
values.
The most common subtype was the ST3 identified in 40% of the subjects, followed by ST1 (29%), ST2 (16%), ST4 (12%), and ST7
(3%). No significant correlation was found between STs distribution and patients' gender. Regarding age, some significant differ-
ence was observed in the distribution of ST1 and ST4 between different age groups, being more prevalent in subjects b40 years
than in the older ones (p = 0.0048 and p = 0.0068, respectively).
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3.3. Bacterial microbiota composition of Blastocystis-ST3 faecal samples
The gut microbiota composition of Blastocystis-colonised patients was investigated by a cross-sectional study on subsample of
patients, as above described, homogeneous by age (b40 years-old) and gender (male) and found positive for the same subtype
(ST3). Thus, 16S rDNA sequencing was performed on a total of 27 male subjects, b40 years old, divided in Blastocystis-ST3-carriers
immunocompetent and immunocompromised (N = 18) and Blastocystis-free subjects (N = 9, control group). A higher bacterial
diversity in faecal microbiota was evidenced in the Blastocystis-ST3 carriers. Indeed, the Chao1 richness index and the observed
OTUs in colonised patients resulted significantly higher than in Blastocystis-free subjects (p = 0.040 and p = 0.038, respectively)
(Table 1 and Fig. 1). The Principal Component Analysis (PCA) plot obtained from the beta-diversity calculation in QIIME demon-
strated a relative clustering of samples, whereby the scores for Factor1 and Factor2 account for 22.33% of the variance in the data.
This difference between the bacterial communities resulted significant, as determined using the ANOSIM nonparametric statistical
test analysis of similarity, where R = 0.18 (p = 0.025) (Fig. 2A).
The composition of gut microbial of Blastocystis-ST3-carriers and Blastocystis-free subjects was further examined evidencing a
relative clustering of the group of subjects (Blastocystis-ST3-carriers and Blastocystis-free) linked to the bacterial communities (Fig.
2B).
In detail, at the phylum level, Firmicutes, Bacteroidetes and Proteobacteria were the most predominant phyla in all patients'
faecal samples with different prevalence values in colonised and not-colonised patients with Blastocystis (53.1% vs 38.2%; 28.3%
vs 45.4%; 8.1% vs 14.3%, respectively). The differences in the relative abundances of OTUs were further analysed using the
Mann-Whitney test at different taxa levels. When comparing Blastocystis-ST3-carriers with free ones, at the class level, a higher
abundance of Bacteroidia was found in Blastocystis-free subjects in comparison with the colonised ones (p = 0.013); while, at
the family level, the presence of Blastocystis is significantly associated with an increased relative abundance of Prevotellaceae,
Methanobacteriaceae, Clostridiaceae Lachnospiraceae, Erysipelotrichaceae and Pasteurellaceae (p = 0.044; p = 0.022; p =
0.005; p = 0.04; p = 0.04; p b 0.001; p = 0.03, respectively), and low level of Bacteroidaceae and Veillonecellaceae
(p b 0.001; p = 0.04, respectively) (Fig. 3).
At the genus level, Prevotella, Methanobrevibacter, Ruminococcus were significantly more abundant in Blastocystis-carriers (p =
0.04; p = 0.02; p = 0.01, respectively), while Bacteroides showed higher abundance in those Blastocystis-free subjects (p b 0.001)
(Fig. 4). As expected, all Blastocystis-ST3-carriers, both immunocompetent and immunocompromised subjects, showed similar fae-
cal microbiota composition, despite a significantly higher relative abundance of Bifidobacteriaceae (p = 0.03) was detected in im-
munocompetent individuals compared to those immunocompromised patients, here analysed.
4. Discussion
This study aimed to describe the occurrence of Blastocystis in patients, mainly Italians, admitted at the Academic Hospital
“Policlinico Umberto I”, Rome, Italy and submitted to microscopical analysis of faecal samples. The protist was detected in
about 8% of the subjects and, as expected, resulted the organism more frequently diagnosed in faecal samples. Despite the micros-
copy is the classical procedure for diagnosing parasitic infections and is still considered the primary and cheapest test offered by
most routine diagnostic services, it exhibits well-known limits regarding the skills and accuracy of the microscopist and the sen-
sitivity (85.9% vs PCR = 100%) (Formenti et al., 2017). In this study the stool microscopy was performed on one to three sample/
patient and a double blinded analysis of each smear was done to assure the diagnostic reliability. Despite a higher prevalence
should be expected using molecular diagnostic tools, the epidemiological scenario described in this study resulted in line with
that from a previously survey (prevalence = 7.1%) on Italian population (Masucci et al., 2011). Molecular methods, herein applied
to 142 out of 192 (74%) microscopy-positive samples, confirmed the copro-parasitological analysis and allowed the subtype iden-
tification. In this study, in addition to the four most common STs identified in humans such as ST1, ST2, ST3, ST4, already iden-
tified in our previous survey (Mattiucci et al., 2016), the ST7 was also detected. This subtype, as the ST5, ST6, ST8 is rarely
identified in humans and therefore, it has been suggested that these rare subtypes in humans are of zoonotic origin (Stensvold
and Clark, 2016).
The occurrence of such STs in Italy was expected, as ST3 was already identified in symptomatic patients (Mattiucci et al., 2016;
Meloni et al., 2011) as well as the ST7 has been preliminarily identified in farmed and edible animals (Gabrielli et al., 2018),
highlighting the risk of transmission of Blastocystis, through animal handling.
Furthermore, in the recent years, several studies in order to address the issue of Blastocystis pathogenicity, suggested that it
could be related to genetic differences on the subtype- or strain-level (Stensvold et al., 2009; Wu et al., 2014), correlating the
Table 1
Comparison of the bacterial richness and diversity in the group of ST3-carriers both immunocompromised and immunocompetent ones and Blastocystis-free subjects.
Statistical analysis was performed using the Kruskal-Wallis test. Significant results were marked with*.
Group of patients (N) Richness estimator
Observed OTUs p-value K-W Chao 1 p-value K-W
Blastocystis-free (9) 340.37 0.038⁎ 365.95 0.040⁎
Blastocystis-ST3 carriers immunocompromised (9) 402.54 432.33
Blastocystis-ST3 carriers immunocompetent (9) 454.38 479.82
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ST-1, 4, and ST-7 with pathological alterations in humans, while ST-2 and ST-3 has been identified as non-pathogenic (Stensvold
et al., 2009; Domínguez-Márquez et al., 2009; Eroglu et al., 2009). Also, the presence of both pathogenic and apathogenic strains
within one subtype has been reported (Hussein et al., 2008). A recent multi-locus sequence typing analysis of Blastocystis ST-3 and
ST-4 has provided valuable insight into genetic variation within and between the two subtypes, evidencing high or low level of
genetic diversity for ST-3 and ST4, respectively (Stensvold et al., 2012). Similar results have been obtained in our previous survey
where 3 haplotypes (H1, H3, H7) have been identified in ST3 isolates, while a single haplotype (H2) was observed in ST4 symp-
tomatic patients (Mattiucci et al., 2016). Thus, we suggested that the intra-subtype diversity showed by ST3 and ST4 could be
linked to the evolutionary history of Blastocystis subtypes and ST3 may have co-evolved with human hosts over a longer period
than ST4, which may has extended its range to humans more recently. Furthermore, it has been demonstrated that Blastocystis
ST7 caused a decrease in beneficial bacteria, such as Bifidobacterium and Lactobacillus (Yason et al., 2019).
In this study, focused on the ST3, Blastocystis was associated to an eubiotic state characterized by a preponderance of poten-
tially beneficial species, belonging to the phyla Firmicutes and Bacteroidetes, such as those of the genera Ruminococcus and
Prevotella, respectively (Iebba et al., 2016b). Furthermore, our results are in line with that reported in other studies (Andersen
et al., 2015; Nieves-Ramírez et al., 2018), which showed the protist significantly more abundant in subjects with Ruminococcus
or Prevotella-driven enterotype and less common in individuals with Bacteroides-driven enterotype (Fig. 4). They also evidenced
that Blastocystis colonisation was linked with higher bacterial richness and lower BMI (Andersen et al., 2015).
Our study confirms and supports this hypothesis evidencing a higher bacterial diversity in Blastocystis-ST3 carriers compared
to that identified in Blastocystis-free individuals (Fig. 1). Moreover, at the family level, Prevotellaceae, Methanobacteriaceae,
Clostridiaceae were also more abundant, whereas Bacteroidaceae were enriched in Blastocystis-free subjects (Figs. 2–3). As ex-
pected, several taxa detected in Blastocystis-carriers included bacteria strictly anaerobes and known to produce butyrate, which
is considered one of the most important metabolite for maintaining health of colon tract in humans, as it serves as the major en-
ergy source of colonocytes, possesses anti-inflammatory properties, and it regulates gene expression, differentiation and apoptosis
in host cells. Butyrate is also required to activate oxidative metabolism and, therefore, to provide low level of oxygen in the gut
lumen. Such eubiotic environment supports continued colonisation by Blastocystis, as was recently elucidated (Stensvold and van
der Giezen, 2018).
Similarly, to that reported for Blastocystis and confirmed also in our survey, several studies evidenced an increase of bacterial
diversity in patients infected by helminths as hookworms and a shift in the composition of the human gut microbiota towards a
‘healthy’ phenotype, as well as increased levels of metabolites with anti-inflammatory properties. According to the Hygiene or Old
Friends hypothesis' (Rook, 2010), certain STs of Blastocystis, such as ST3, would be considered as ‘old friends’ (Mattiucci et al.,
2016), as in the case hookworms. They may be required for maintaining the intestinal homeostasis and/or play a role as a marker
of intestinal homeostasis (Stensvold and van der Giezen, 2018).
Fig. 1. Boxplot of Chao1 diversity index between Blastocystis-free and Blastocystis-ST3-carriers divided in immunocompromised and immunocompetent subjects.
Statistical analysis was performed using the Kruskal-Wallis (K-W) test.
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Fig. 2. Analyses of the variance in bacterial microbiota composition at the family taxonomic rank observed in Blastocystis-ST3 carriers and Blastocystis-free subjects
A) PCA plot of microbial communities in Blastocystis-ST3 carriers (red dots) and Blastocystis-free subjects (blue dots); B) eigenvectors of correlation matrix of mi-
crobial communities in the 2 groups of subjects. RF39: unclassified Enterococcaceae; YS2: Cyanobacteria.
Fig. 3. Comparisons of the median values of the relative abundance at the level of bacterial family (level 5) for Bacteroidaceae, Prevotellaceae,
Methanobacteriaceae, Clostridiaceae, Lachnospiraceae, Veillonellaceae, Erysipelotrichaceae, Pasteurellaceae in Blastocystis-carriers and Blastocystis-free subjects (or-
ange and blue bars, respectively). The Mann-Whitney test was used to evaluate the 2 groups.
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Although Blastocystis was never considered as an opportunistic organism, it has also been frequently found in immunocompro-
mised individuals presenting diarrhoea, with prevalence value ranging from 15% to 72.4% (Tan et al., 2009). In this study,
Blastocystis was more frequently identified in faecal samples from HIV-positive patients (22%) than in immunocompetent subjects
(7%) reporting values in line with previously surveys (Piranshahi et al., 2018; Tan et al., 2009). However, no significant differences
in faecal microbiota composition was found between HIV-positive and immunocompetent subjects, despite immunocompromised
individuals showed low level of bacterial richness (Fig. 1). Several Authors have evaluated the intestinal microbiome in HIV-
positive subjects, with somewhat inconsistent or controversial results (Williams et al., 2016). This may be because of small sample
sizes, lack of appropriate controls, and/or regional differences in dietary and environmental factors. Regardless, many authors ev-
idenced a change in the ratio Bacteroides:Prevotella; this finding has been suggested to be linked to the antiretroviral therapy
(Vesterbacka et al., 2017; Ling et al., 2016), and/or to the sexual practice and lifestyle (Noguera-Julian et al., 2016).
Faecal samples from our HIV-positive patients exhibited the so-called Prevotella enterotype (or enterotype II), which character-
izes the HIV-positive treated patients (Lozupone et al., 2013; Vujkovic-Cvijin et al., 2013) and, as above described, favours the
Blastocystis colonisation. Taking these observations into account, it appears that the high prevalence of Blastocystis observed in
these patients is a consequence of the microbiota composition which highly supports the colonisation by the protist.
In conclusion, despite large-scale surveys using molecular approaches would be needed to assess the Blastocystis epidemiology
in Italy, the present study characterized Blastocystis-subtypes from several faecal samples collected from subjects with different
immunological status, evidencing a high circulation of the protist in immunocompromised individuals. Zoonotic STs as ST7
were identified in humans highlighting the risk of Blastocystis transmission from animals. Despite the study of the microbiota
composition was performed on few subjects mainly Italians colonised by the ST3, the results so far obtained confirm the associ-
ation between the presence of the protist, and a greater bacterial diversity with the high occurrence of Prevotella and
Ruminococcus-enterotype and with a eubiotic gut. Surely, more investigations on the relationship between the intra-subtype var-
iability or haplotypes and the gut microbiota are needed to confirm this positive association.
As the subtype identification and intra-subtype variability seems to be essential for assessing the relationship between
Blastocystis, microbiota profile and human disease, further studies on the gut microbiota in patients colonised by different STs
at the inter- and intra-subtype level should be enhanced, as well as affected by other immunological disorders in order to add
knowledge on the potential role played by this protist in the human gut microbiota composition.
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